We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$726B
AUM Growth
+$72B
Cap. Flow
+$18.3B
Cap. Flow %
2.52%
Top 10 Hldgs %
22.02%
Holding
4,790
New
331
Increased
3,384
Reduced
720
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 23.98%
2 Financials 13.87%
3 Healthcare 13.39%
4 Consumer Discretionary 11.81%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TLSI icon
4376
TriSalus Life Sciences
TLSI
$279M
$181K ﹤0.01%
18,606
+1,341
+8% +$13.1K
TMPO
4377
DELISTED
Tempo Automation Holdings, Inc. Common Stock
TMPO
$181K ﹤0.01%
+18,248
New +$182K
GRNA
4378
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$181K ﹤0.01%
+18,521
New +$181K
EZRA
4379
Reliance Global Group
EZRA
$1.49M
$179K ﹤0.01%
5
+1
+25% +$37.1K
IFMK
4380
DELISTED
iFresh Inc. Common Stock
IFMK
$179K ﹤0.01%
127,107
+27,771
+28% +$38.3K
SVA
4381
DELISTED
Sinovac Biotech, Ltd
SVA
$179K ﹤0.01%
27,717
OPNT
4382
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$178K ﹤0.01%
12,882
PROF
4383
Profound Medical
PROF
$268M
$177K ﹤0.01%
+10,870
New +$202K
FSSI
4384
DELISTED
Fortistar Sustainable Solutions Corp. Class A Common Stock
FSSI
$177K ﹤0.01%
+18,237
New +$178K
KOR
4385
DELISTED
Corvus Gold Inc. Common Shares
KOR
$177K ﹤0.01%
64,859
+14,605
+29% +$36.9K
NAVB
4386
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$177K ﹤0.01%
97,206
+22,064
+29% +$39K
STRR
4387
Star Equity Holdings
STRR
$39.9M
$176K ﹤0.01%
10,096
HYZN
4388
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$174K ﹤0.01%
+339
New +$174K
DNN icon
4389
Denison Mines
DNN
$2.54B
$173K ﹤0.01%
+142,708
New +$171K
PAQC
4390
DELISTED
Provident Acquisition Corp. Class A Ordinary Shares
PAQC
$173K ﹤0.01%
+17,899
New +$174K
THER
4391
DELISTED
THERATECHNOLOGIES INC COM
THER
$173K ﹤0.01%
44,667
WHLM
4392
DELISTED
Wilhelmina International, Inc
WHLM
$172K ﹤0.01%
+34,476
New +$190K
PRQR icon
4393
ProQR Therapeutics
PRQR
$243M
$171K ﹤0.01%
25,405
+5,873
+30% +$37.9K
UHG
4394
DELISTED
United Homes Group
UHG
$171K ﹤0.01%
+17,651
New +$172K
PTIX
4395
DELISTED
Performance Technologies
PTIX
$170K ﹤0.01%
+1,055
New +$152K
RAVE icon
4396
RAVE Restaurant Group
RAVE
$44.8M
$170K ﹤0.01%
115,398
COVA
4397
DELISTED
COVA Acquisition Corp. Class A Ordinary Share
COVA
$170K ﹤0.01%
+17,610
New +$171K
BLTS
4398
DELISTED
Bright Lights Acquisition Corp. Class A Common Stock
BLTS
$170K ﹤0.01%
+17,617
New +$172K
MNPR icon
4399
Monopar Therapeutics
MNPR
$726M
$169K ﹤0.01%
5,752
+473
+9% +$13.5K
SLNH icon
4400
Soluna Holdings
SLNH
$192M
$168K ﹤0.01%
+899
New +$188K

Similar funds

Geode Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
  • Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
  • Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
  • Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
  • Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
  • Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
  • Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.

Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.